Morgan Motor Company originally thought their most important asset was their range of hand built sports cars, after working Wynne-Jones, they realised their most important asset was their brand.
The Morgan Motor Company are arguably one the most striking sports car manufacturers around, with celebrity fans such as Jay Leno and James May to car enthusiasts the world over.
For Morgan, partnering with Wynne-Jones presented an opportunity to not only tap into the wealth of historic IP, but also to protect future interests, such as a planned entry into the electric car market.
Wynne-Jones delivered an in-depth audit through regular meetings to ensure that Morgan's interests were always properly represented, and the senior leadership team at Morgan were thrilled with the results.
You can watch a short video case study here:
Morgan is an excellent example of how vigilant IP management is crucial, especially during times of uncertainty such as the current UK-wide lockdown. As part of a solid risk management plan you need to identify your IP assets and assess whether they are business critical. Being business critical means that the IP assets are essential to the delivery of your business goals once the COVID-19 crisis is over, and perhaps even during the crisis.
In-depth audits like the work provided for Morgan are the best way to identify, mitigate and maximise these areas in your IP portfolio - allowing you to move forward with assured certainty in uncertain times.
Top Cat helps Dibble nab Copy Cats
It’s news that could make Amazon the most tip top Top Cat among toy and game designers, inventors and parents worldwide.
The retailer has announced the establishment of a Counterfeit Crimes Unit that will be tasked with bringing copycats to justice. The Counterfeit Crimes Unit is composed of former federal prosecutors, data analysts and investigators and will be charged with bringing sellers that break not only law, but Amazon’s policies, to justice.
UK Supreme Court judgment: Regeneron v Kymab
On 24 June 2020, the UK Supreme Court handed down its landmark judgment in Regeneron Pharmaceuticals Inc v Kymab Ltd  UKSC 27 in a dispute that has been rumbling on for seven years. It was good news for Kymab and bad news for Regeneron, which saw two of its patents invalidated. For the rest of us, it’s an important case which includes key rulings on insufficiency.
Coronavirus - UK IPO, EPO and EU IPO extensions and support
A simple overview of the current status from IPOs. Last updated 18th May 2020.
Is it unethical to patent?
The Covid-19 pandemic has prompted many companies to invest time and effort in developing technology that is aimed at helping care for, test, or treat people suffering from the disease. In normal times, these might be considered normal commercial activities and would be considered for patenting without a second thought. However, the fact that these developments are typically not being motivated by pure commercial gain, but by a desire to do something for the public good causes many companies to question whether or not they should seeks patents or any other form of intellectual property protection.